What is NDC 68180-265?

68180-265 is the product NDC for Divalproex Sodium, Divalproex sodium 125 mg/1 tablet, delayed release, listed with the FDA by Lupin Pharmaceuticals, Inc..

Lupin Pharmaceuticals, Inc., NDC labeler code 68180. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Divalproex Sodium?

185 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Divalproex Sodium NDC 68180-265 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)68180-265Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68180-0265Add the package segment from the table below.

Product information

Brand name (proprietary): Divalproex Sodium
Generic name (nonproprietary): divalproex sodium
Active ingredients: Divalproex sodium — 125 mg/1
Dosage form: Tablet, Delayed release
Route: Oral
Labeler: Lupin Pharmaceuticals, Inc.NDC labeler code 68180
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078790
Marketing start: Jul 29, 2008
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 68180-265_0a9f300c-ee8c-43c4-bccf-78cd862a7ac2SPL ID 0a9f300c-ee8c-43c4-bccf-78cd862a7ac2SPL set ID 33798a7c-c5a9-49a5-be5d-1312910ef468RxCUI 1099625, 1099678, 1099870UNII 644VL95AO6UPC 0368180267010
Pharmacologic class: Anti-epileptic Agent; Mood Stabilizer

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match: No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

Product label

Current FDA label (SPL), effective May 5, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Divalproex sodium delayed-release tablet is an anti-epileptic drug indicated for: Treatment of manic episodes associated with bipolar disorder ( 1.1 ) Monotherapy and adjunctive therapy of complex partial seizures and simple and complex absence seizures; adjunctive therapy in patients with multiple seizure types that include absence seizures ( 1.2 ) Prophylaxis of migraine headaches ( 1.3 ) 1.1 Mania Divalproex sodium delayed-release tablet is a valproate and is indicated for the treatment of the manic episodes associated with bipolar disorder. A manic episode is a distinct period of abnormally and persistently elevated, expansive, or irritable mood. Typical symptoms of mania include pressur…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68180-265

What is NDC 68180-265?: 68180-265 is the product NDC for Divalproex Sodium, Divalproex sodium 125 mg/1 tablet, delayed release, listed with the FDA by Lupin Pharmaceuticals, Inc..
What drug is associated with this NDC?: Divalproex Sodium.
What is the active ingredient?: Divalproex sodium.
Who is the labeler?: Lupin Pharmaceuticals, Inc., NDC labeler code 68180. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Divalproex Sodium?: 185 other product NDCs are listed under this name. See all Divalproex Sodium NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Divalproex Sodium NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
divalproex sodium	Divalproex sodium 250 mg/1	Tablet, Film coated, Extended releaseOral	Coupler LLC	67046-1696	67046-1696-03
Divalproex Sodium	Divalproex sodium 500 mg/1	Tablet, Delayed releaseOral	Cardinal Health 107, LLC	55154-0577	55154-0577-00
divalproex sodium	Divalproex sodium 500 mg/1	Tablet, Film coated, Extended releaseOral	Preferred Pharmaceuticals Inc.	68788-4193	68788-4193-0368788-4193-0668788-4193-09
divalproex sodium	Divalproex sodium 250 mg/1	Tablet, Delayed releaseOral	Coupler LLC	67046-1683	67046-1683-03
Divalproex Sodium	Divalproex sodium 250 mg/1	Tablet, Delayed releaseOral	Unit Dose Solutions, Inc.	87441-027	87441-0027-01
Divalproex Sodium	Divalproex sodium 500 mg/1	Tablet, Delayed releaseOral	Unit Dose Solutions, Inc.	87441-028	87441-0028-01
Divalproex Sodium	Divalproex sodium 250 mg/1	Tablet, Extended releaseOral	Coupler LLC	67046-2021	67046-2021-03
Divalproex Sodium	Divalproex sodium 500 mg/1	Tablet, Extended releaseOral	Preferred Pharmaceuticals Inc.	68788-4100	68788-4100-0368788-4100-0668788-4100-09
Divalproex Sodium	Divalproex sodium 250 mg/1	Tablet, Film coated, Extended releaseOral	Safecor Health, LLC	48433-033	48433-0033-08
Divalproex Sodium	Divalproex sodium 500 mg/1	Tablet, Film coated, Extended releaseOral	Safecor Health, LLC	48433-034	48433-0034-08

All 186 Divalproex Sodium NDCs

Other NDCs under ANDA 078790

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 078790
Product	Strength	Form · route	Labeler	Product NDC
Divalproex Sodium	Divalproex sodium 250 mg/1	Tablet, Delayed releaseOral	Lupin Pharmaceuticals, Inc.	68180-266
Divalproex Sodium	Divalproex sodium 500 mg/1	Tablet, Delayed releaseOral	Lupin Pharmaceuticals, Inc.	68180-267